Overview (Program Summary)
Please mark your calendars for this Virtual CLE Institute, and check back often for program updates!
Session I, 9:00 a.m. to 10:00 a.m. - Manko Gold Katcher Fox LLP
Being Prepared to Respond to the Next Emergency
REGISTRATION LINK: https://acc.inreachce.com/Details/Information/e8c66c19-553f-4127-bc5a-9655fde00e6d
With the increased occurrence of climate-related emergencies, such as hurricanes, floods and now a viral pandemic, it is now more important than ever to ensure that your company is in compliance with its emergency response planning obligations. Understanding and complying with the applicable requirements can help your company be both prepared and more resilient to the next disaster. In this session, we will review relevant provisions of the Emergency Planning and Community Right-to-Know Act, the Clean Air Act and OSHA’s Emergency Planning and Process Safety Management Standards, discuss how the requirements interrelate, and suggest useful tools for successful emergency planning.
Session II, 10:30 a.m. to 11:30 a.m. - Womble Bond Dickinson (US) LLP
Where Do We Stand (or Fall): An Evaluation of Trends in Drug Cost Transparency and 340B Pricing Program Legislation
REGISTRATION LINK: https://acc.inreachce.com/Details/Information/9b7219d1-918c-4825-823e-49dff2b86593
With the stated objective of lowering drug prices and increasing transparency, many state governments have enacted drug costs transparency laws. Simultaneously, both state and federal governments have introduced and enacted legislation aimed at the 340B Drug Pricing Program. Join us in a discussion of the trends and compliance lessons garnered from these legislative developments.
Session III, 12:00 p.m. to 1:00 p.m - Armstrong Teasdale LLP
United States v. Black: Implications for Internal Investigations
REGISTRATION LINK: https://acc.inreachce.com/Details/Information/b9706cff-90eb-41f7-9745-6d6e06a18084
In May 2019, the Southern District of New York found that lawyers for Deutsche Bank effectively acted as government agents in the investigation into manipulation of the LIBOR benchmark rate that resulted in the conviction of Deutsche Bank employee Gavin Black. Although the Court found that Black’s interview with outside counsel as part of that investigation was unconstitutionally compelled, it upheld his conviction because it found no Garrity violation had occurred. Join our expert panelists for a discussion of the implications that corporate counsel in the health, biotech and pharma industries should consider when conducting internal investigations, including the impact of Black upon internal investigations, the role of in-house counsel, the role of outside counsel, and counsels’ interactions with the government as they run concurrent investigations.
- Jill Hyman Kaplan, Partner, Manko Gold Katcher Fox LLP
- Michael C. Nines, P.E., LEED AP, Technical Consultant, Manko Gold Katcher Fox LLP
- William S. Pufko, Chief Counsel-Environment, Health, Safety & Sustainability, Bristol-Myers Squibb
- Antonia (Toni) A. Peck, Partner, Womble Bond Dickinson (US) LLP
- Brian Savage, General Counsel-US Generics, TEVA Pharmaceuticals
- Richard L. Scheff, Partner and Leader - Eastern U.S., Armstrong Teasdale LLP
- Carrie Sarhangi Love, Partner, Armstrong Teasdale LLP
- Arunabha Bhoumik, Senior Director of Dispute Resolution, Regeneron Pharmaceuticals, Inc.,